Zordani Richard A. Jr.'s Form 4 filing
Galectin Therapeutics Inc (GALT) · filed Aug 26, 2024
- Accession no.
- 0001133416-24-000054
- Filed
- Aug 26, 2024
- Trade date
- Aug 22-23, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $8.05K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Zordani Richard A. Jr.CIK 0001827180 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 23, 2024 | Common Stock | PPurchaseAcquired | +1,000 | $2.30 | +$2,300 | 2,000 | Indirect | |
| Aug 22, 2024 | Common Stock | PPurchaseAcquired | +741 | $2.30 | +$1,704.3 | 30,324 | Direct | |
| Aug 23, 2024 | Common Stock | PPurchaseAcquired | +1,759 | $2.30 | +$4,045.7 | 32,083 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.